MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Edwards Lifesciences Corp

Cerrado

SectorSanidad

73.07 1.36

Resumen

Variación precio

24h

Actual

Mínimo

70.56

Máximo

73.22

Métricas clave

By Trading Economics

Ingresos

-2.7B

346M

Ventas

31M

1.4B

P/B

Media del Sector

30.714

63.778

BPA

0.59

Margen de beneficios

24.989

Empleados

15,800

EBITDA

55M

484M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+7.89% upside

Dividendos

By Dow Jones

Próximas Ganancias

23 abr 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-1.1B

42B

Apertura anterior

71.71

Cierre anterior

73.07

Noticias sobre sentimiento de mercado

By Acuity

22%

78%

55 / 386 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Edwards Lifesciences Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

15 jul 2024, 13:57 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences to Buy Innovalve for $300 Million

25 oct 2024, 09:10 UTC

Ganancias

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

25 oct 2024, 08:35 UTC

Ganancias

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

3 sept 2024, 20:38 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences: After Recent Accelerated Repurchase Agreement and August Buybacks Via 10b5-1 Agreement and Open Market Repurchases, Company Has $1.4B in Remaining Authorization

3 sept 2024, 20:37 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences Completes Sale of Critical Care Group to Becton Dickinson for $4.2B

3 sept 2024, 20:36 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences Authorizes $1.5B of Additional Share Repurchases

25 jul 2024, 09:02 UTC

Ganancias
Acciones populares

Stocks to Watch Thursday: Ford, IBM, Chipotle, American Airlines -- WSJ

25 jul 2024, 08:40 UTC

Principales Noticias

These Stocks Are Moving the Most Today: Ford, Tesla, Alphabet, Nvidia, Super Micro, IBM, ServiceNow, Chipotle, and More -- Barrons.com

24 jul 2024, 20:17 UTC

Ganancias

Edwards Lifesciences: Expects 2024 Edwards Sales Growth of 8% to 10% >EW

24 jul 2024, 20:15 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

24 jul 2024, 20:15 UTC

Ganancias

Edwards Lifesciences 2Q Sales $1.39B >EW

24 jul 2024, 20:15 UTC

Ganancias

Edwards Lifesciences 2Q Net $366.3M >EW

24 jul 2024, 20:15 UTC

Ganancias

Edwards Lifesciences 2Q Adj EPS 70c >EW

24 jul 2024, 20:15 UTC

Ganancias

Edwards Lifesciences 2Q EPS 61c >EW

15 jul 2024, 13:42 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences to Buy Innovalve for $300M

15 jul 2024, 13:01 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences: SAPIEN M3 Remains on Track to Become First Approved Transfemoral TMVR System in Europe by End of 2025 >EW

15 jul 2024, 13:01 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences: Acquisition Enhances TMVR Technologies to Address Large Unmet Structural Heart Patient Needs >EW

15 jul 2024, 13:00 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences to Acquire Innovalve Bio Medical Ltd., Early-Stage Transcatheter Mitral Valve Replacement Co >EW

15 jul 2024, 13:00 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences To Acquire Innovalve >EW

4 jun 2024, 17:26 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences Deal A Clear Win For Becton Dickinson, Analysts Say -- Analysis

3 jun 2024, 13:26 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal -- IBD

3 jun 2024, 12:25 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash -- Update

3 jun 2024, 11:03 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2B in Cash

3 jun 2024, 10:40 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences To Sell Its Critical Care Product Group For $4.2 Billion To Becton Dickinson -- MarketWatch

3 jun 2024, 10:32 UTC

Adquisiciones, fusiones, absorciones

Becton Dickinson: Acquired Business Has About 4,500 Employees >BDX EW

3 jun 2024, 10:31 UTC

Adquisiciones, fusiones, absorciones

Becton Dickinson: Acquired Business Generated More Than $900 Million Revenue in 2023 >BDX

3 jun 2024, 10:31 UTC

Adquisiciones, fusiones, absorciones

Becton Dickinson: Deal Expands Portfolio of Smart Connected Care Solutions >BDX EW

3 jun 2024, 10:30 UTC

Adquisiciones, fusiones, absorciones

Becton Dickinson to Buy Edwards Lifesciences Critical Care Product Group for $4.2 Billion >BDX EW

3 jun 2024, 10:30 UTC

Adquisiciones, fusiones, absorciones

BD To Acquire Edwards Lifesciences' Critical Care Product Group For $4.2 Billion To Expand Smart Connected Care Solutions And Become An Advanced Monitoring Technology Leader >BDX EW

26 abr 2024, 20:10 UTC

Ganancias

This 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss -- IBD

Comparación entre iguales

Cambio de precio

Edwards Lifesciences Corp previsión

Precio Objetivo

By TipRanks

7.89% repunte

Estimación a 12 Meses

Media 77.54 USD  7.89%

Máximo 90 USD

Mínimo 60 USD

De acuerdo con 19 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Edwards Lifesciences Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

19 ratings

7

Comprar

11

Mantener

1

Vender

Puntuación técnica

By Trading Central

71.2 / 72.48Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Weak Bullish Evidence

Sentimiento

By Acuity

55 / 386 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.